Contents Kristine Nash-Wong, Marketing Manager at HealthMedia, speaks about reputation enhancement. Dr. Thomas Wicks, VP of Regulatory Affairs at Odyssey Pharmaceuticals, talks about continuing treatment innovation while limiting costs. Scott Szwast, Sector Marketing Manager at UPS Supply Chain Solutions, talks about the supply chain. Dr. J. David Haddox, VP of Risk Management and Health Policy at Purdue Pharma, discusses patient safety. Special Issue The Pulse of the Industry: Year in Preview Topics and trends 8 introduction 9 business models 10 Leadership Will Make or Break Pharma Companies in 2005 10 Industry Trends to Watch 13 The Pharmaceutical Industry is No Longer a Growth Industry 14 Pharmaceutical Industry Success Dependent on Better Product Life-Cycle Management 16 CDISC Study Data Tabulation Model 17 Drug Development 17 Strong Clinical-Trial Management Systems Market Offers Opportunities for Suppliers, Clinical Sponsors, and CROs Alike 18 Content Management Providers May Challenge Growth for PLM’s New Product Data-Management Strategy 20 Tactics to Reduce Development Cycle Times 26 Financing 28 Global Issues 30 $28 Billion In Vitro Diagnostic Industry Comes Alive with Innovations and New Markets 32 Importation/Price Controls 33 The Rationale for Combining Health Economics and Strategic Reimbursement Planning 34 Drug Importation May Result in Higher, Not Lower, Consumer Costs 36 Innovation 38 Intellectual Property 40 Marketing/Promotion 42 Copromotion/Comarketing of Pharmaceuticals 43 Medical Education 44 Choosing Educational Partners: Keys to Successful CME Collaboration 46 Medicare 47 Multifunctional Teams 50 Patient Safety 51 Follow-on Drugs Improve Patient Safety and Help Reduce Costs 52 Regulatory 53 FDA Acts to Strengthen the Safety Program for Marketed Drugs 55 Reputation Enhancement 58 Risk Management 59 Salesforces 60 The Salesforce Arms Race 62 Increase in Turnover of Pharma Sales Reps 63 Shareholder Value 65 Supply Chain 66 Technology 67 Big Changes Ahead for Technology-Based Pharmaceutical Detailing 67 Allied Health Professionals Are Primed for E-Details 68 12-Month Spending Outlook Positive; Clinical-Trials Area Leads in Optimism in every issue 3 Letter from the Editor
